These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 26406956

  • 1. HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifier.
    Brentnall AR, Vasiljevic N, Scibior-Bentkowska D, Cadman L, Austin J, Cuzick J, Lorincz AT.
    Cancer Biomark; 2015; 15(5):669-75. PubMed ID: 26406956
    [Abstract] [Full Text] [Related]

  • 2. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
    Hernández-López R, Lorincz AT, Torres-Ibarra L, Reuter C, Scibior-Bentkowska D, Warman R, Nedjai B, Mendiola-Pastrana I, León-Maldonado L, Rivera-Paredez B, Ramírez-Palacios P, Lazcano-Ponce E, Cuzick J, Salmerón J, FRIDA Study Group.
    Clin Epigenetics; 2019 Oct 12; 11(1):140. PubMed ID: 31606044
    [Abstract] [Full Text] [Related]

  • 3. Validation of a DNA methylation HPV triage classifier in a screening sample.
    Lorincz AT, Brentnall AR, Scibior-Bentkowska D, Reuter C, Banwait R, Cadman L, Austin J, Cuzick J, Vasiljević N.
    Int J Cancer; 2016 Jun 01; 138(11):2745-51. PubMed ID: 26790008
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term prediction by DNA methylation of high-grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort.
    Gilham C, Nedjai B, Scibior-Bentkowska D, Reuter C, Banwait R, Brentnall AR, Cuzick J, Peto J, Lorincz AT.
    Int J Cancer; 2024 Jul 01; 155(1):81-92. PubMed ID: 38507581
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846
    [Abstract] [Full Text] [Related]

  • 7. DNA methylation testing with S5 for triage of high-risk HPV positive women.
    Adcock R, Nedjai B, Lorincz AT, Scibior-Bentkowska D, Banwait R, Torrez-Martinez N, Robertson M, Cuzick J, Wheeler CM, New Mexico HPV Pap Registry Steering Committee.
    Int J Cancer; 2022 Oct 01; 151(7):993-1004. PubMed ID: 35477862
    [Abstract] [Full Text] [Related]

  • 8. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM.
    Lancet Oncol; 2011 Sep 01; 12(9):880-90. PubMed ID: 21865084
    [Abstract] [Full Text] [Related]

  • 9. A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers.
    Vasiljević N, Scibior-Bentkowska D, Brentnall A, Cuzick J, Lorincz A.
    J Clin Virol; 2014 Mar 01; 59(3):161-6. PubMed ID: 24468012
    [Abstract] [Full Text] [Related]

  • 10. Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.
    Fu Xi L, Schiffman M, Ke Y, Hughes JP, Galloway DA, He Z, Hulbert A, Winer RL, Koutsky LA, Kiviat NB.
    Int J Cancer; 2017 Apr 15; 140(8):1747-1756. PubMed ID: 28052328
    [Abstract] [Full Text] [Related]

  • 11. Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer Prevention.
    Lorincz AT.
    Acta Cytol; 2016 Apr 15; 60(6):501-512. PubMed ID: 27806357
    [Abstract] [Full Text] [Related]

  • 12. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M, Oštrbenk A, Seme K, Šterbenc A, Jančar N, Vrtačnik Bokal E.
    J Clin Virol; 2016 Mar 15; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [Abstract] [Full Text] [Related]

  • 13. Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
    Bukowski A, Hoyo C, Hudgens MG, Brewster WR, Valea F, Bentley RC, Vidal AC, Maguire RL, Schmitt JW, Murphy SK, North KE, Smith JS.
    Cancer Epidemiol Biomarkers Prev; 2022 Aug 02; 31(8):1564-1571. PubMed ID: 35654413
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial.
    Cook DA, Krajden M, Brentnall AR, Gondara L, Chan T, Law JH, Smith LW, van Niekerk DJ, Ogilvie GS, Coldman AJ, Warman R, Reuter C, Cuzick J, Lorincz AT.
    Int J Cancer; 2019 May 15; 144(10):2587-2595. PubMed ID: 30412281
    [Abstract] [Full Text] [Related]

  • 15. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
    Tao X, Zhang H, Zhang H, Xiao Y, Zhong F, Zhou X, Cong Q, Sui L, Zhao C.
    Cancer Cytopathol; 2022 Jul 15; 130(7):542-550. PubMed ID: 35312217
    [Abstract] [Full Text] [Related]

  • 16. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.
    Wentzensen N, Sun C, Ghosh A, Kinney W, Mirabello L, Wacholder S, Shaber R, LaMere B, Clarke M, Lorincz AT, Castle PE, Schiffman M, Burk RD.
    J Natl Cancer Inst; 2012 Nov 21; 104(22):1738-49. PubMed ID: 23093560
    [Abstract] [Full Text] [Related]

  • 17. Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.
    Verhoef VM, Heideman DA, van Kemenade FJ, Rozendaal L, Bosgraaf RP, Hesselink AT, Bekkers RL, Massuger LF, Steenbergen RD, Snijders PJ, Berkhof J, Meijer CJ.
    Gynecol Oncol; 2014 Oct 21; 135(1):58-63. PubMed ID: 25111387
    [Abstract] [Full Text] [Related]

  • 18. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK, Frederiksen K, Munk C, Iftner T.
    J Natl Cancer Inst; 2010 Oct 06; 102(19):1478-88. PubMed ID: 20841605
    [Abstract] [Full Text] [Related]

  • 19. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F, Du H, Wang C, Huang X, Wu R, CHIMUST team.
    PLoS One; 2020 Oct 06; 15(6):e0234518. PubMed ID: 32525936
    [Abstract] [Full Text] [Related]

  • 20. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH.
    J Gynecol Oncol; 2017 Jul 06; 28(4):e30. PubMed ID: 28541628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.